Cargando…
Raloxifene Stimulates Estrogen Signaling to Protect Against Age- and Sex-Related Intervertebral Disc Degeneration in Mice
Estrogen agonist raloxifene is an FDA-approved treatment of osteoporosis in postmenopausal women, which may also be a promising prophylactic for painful intervertebral disc (IVD) degeneration. Here, we hypothesized that 1) aging and biological sex contribute to IVD degeneration by reducing estrogen...
Autores principales: | Bhadouria, Neharika, Berman, Alycia G., Wallace, Joseph M., Holguin, Nilsson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404526/ https://www.ncbi.nlm.nih.gov/pubmed/36032728 http://dx.doi.org/10.3389/fbioe.2022.924918 |
Ejemplares similares
-
Editorial: Biomaterial advances in intervertebral disc degeneration
por: Huang, Yong, et al.
Publicado: (2023) -
Editorial: Cell-based therapeutics for intervertebral disc degeneration
por: Li, Zhen, et al.
Publicado: (2023) -
Senolytics: Eliminating Senescent Cells and Alleviating Intervertebral Disc Degeneration
por: Wu, Yuhao, et al.
Publicado: (2022) -
Innovative immune mechanisms and antioxidative therapies of intervertebral disc degeneration
por: Wei, Bingqian, et al.
Publicado: (2022) -
Application of stem cells combined with biomaterial in the treatment of intervertebral disc degeneration
por: Liu, Zongtai, et al.
Publicado: (2022)